Product Description
Artesunate is a semi‑synthetic artemisinin derivative. It rapidly kills malaria parasite erythrocytic stage, inhibits parasite membrane formation and protein synthesis, takes effect fast, has low drug resistance and high safety. It is the first‑line choice for severe malaria rescue and alternative treatment for ordinary malaria, widely used in malaria endemic regions worldwide.
Indications
- Severe falciparum malaria
- Cerebral malaria
- Malaria with organ dysfunction, high fever or critical condition
- Uncomplicated malaria unable to take oral medicine
- Malaria prevention and emergency treatment in endemic areas
Administration
Reconstitute with dedicated solvent strictly per protocol. Administer by intravenous or intramuscular injection. Dosage calculated by patient body weight; follow standard malaria treatment guidelines.
Product Features
- Standard 80mg per vial lyophilized powder
- Fast parasite clearance, rapid fever reduction
- High efficacy, low toxicity, low resistance rate
- Suitable for adults and children
- WHO recommended first‑line severe malaria medicine
Storage
Store sealed, protected from light, cool dry place; avoid high temperature and humidity.
Warnings
- Prescription only, used under medical supervision in malaria endemic areas or hospital.
- Contraindicated in hypersensitivity to artesunate or artemisinin derivatives.
- Follow full treatment course to avoid recurrence.
- Use cautiously in pregnancy and lactation under doctor assessment.
- Keep out of reach of children.
